These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22401630)

  • 1. Conference scene: progress with promising human antibodies.
    Larrick JW
    Immunotherapy; 2012 Mar; 4(3):257-61. PubMed ID: 22401630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
    Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
    MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state of antibody therapy.
    Elbakri A; Nelson PN; Abu Odeh RO
    Hum Immunol; 2010 Dec; 71(12):1243-50. PubMed ID: 20849901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
    Zangemeister-Wittke U
    Pathobiology; 2005; 72(6):279-86. PubMed ID: 16582579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.
    Klöhn PC; Wuellner U; Zizlsperger N; Zhou Y; Tavares D; Berger S; Zettlitz KA; Proetzel G; Yong M; Begent RH; Reichert JM
    MAbs; 2013; 5(2):178-201. PubMed ID: 23575266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic antibodies market to 2008.
    Pavlou AK; Belsey MJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the production and downstream processing of antibodies.
    Chon JH; Zarbis-Papastoitsis G
    N Biotechnol; 2011 Sep; 28(5):458-63. PubMed ID: 21515428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab: an insider's historical perspective.
    Grillo-López AJ
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):9-16. PubMed ID: 11226006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody "gold rush".
    Maggon K
    Curr Med Chem; 2007; 14(18):1978-87. PubMed ID: 17691940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?
    Dimitrov DS; Marks JD
    Methods Mol Biol; 2009; 525():1-27, xiii. PubMed ID: 19252861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kuwait.
    United States. Department of State. Bureau of Public Affairs
    Backgr Notes Ser; 1988 Mar; ():1-8. PubMed ID: 12177972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.
    Pauthner M; Yeung J; Ullman C; Bakker J; Wurch T; Reichert JM; Lund-Johansen F; Bradbury AR; Carter PJ; Melis JP
    MAbs; 2016; 8(3):617-52. PubMed ID: 26909869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
    Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
    MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic monoclonal antibody market.
    Ecker DM; Jones SD; Levine HL
    MAbs; 2015; 7(1):9-14. PubMed ID: 25529996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.